Skip to main content
Livermore
Livermore
ZHEN

Karuna Therapeutics, Inc.

KRTXDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001771917

Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Karuna Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of KRTX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1783195+20
Shares29.5M47.8K29.9M+402.0K (+1.4%)
Value$3.73B$6.06M$3.77B+$41.4M (+1.1%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to KRTX in Q2 2022
InstitutionSharesValue% of portfolio
Avidity Partners Management LP204,570$25.9M0.59%
Great Point Partners LLC149,000$18.9M4.86%
Casdin Capital, LLC85,000$10.8M0.91%
Balyasny Asset Management LLC72,802$9.21M0.04%
Pura Vida Investments, LLC29,900$3.78M0.60%
Renaissance Technologies LLC27,000$3.42M0.00%
Sectoral Asset Management Inc24,020$3.04M0.61%
Moody Aldrich Partners LLC19,920$2.52M0.50%
Tudor Investment Corp Et Al14,927$1.89M0.06%
Bank of Montreal10,475$1.28M0.00%
DLD Asset Management, LP10,000$1.26M0.10%
ExodusPoint Capital Management, LP7,368$932.0K0.01%
CSS LLC5,676$718.0K0.03%
D. E. Shaw & Co., Inc.5,460$691.0K0.00%
Clarius Group, LLC5,452$690.0K0.07%
Worth Venture Partners, LLC4,800$640.0K0.39%
Quantamental Technologies LLC4,881$617.0K0.28%
Gsa Capital Partners LLP4,866$616.0K0.09%
Hennion & Walsh Asset Management, Inc.3,809$482.0K0.03%
Winton Group Ltd3,719$470.0K0.02%
Magnetar Financial LLC3,133$396.0K0.00%
Glenmede Trust Co NA2,698$341.0K0.00%
AQR Capital Management LLC2,513$318.0K0.00%
Envestnet Asset Management Inc2,428$307.0K0.00%
Arrowstreet Capital, Limited Partnership2,111$267.0K0.00%
Bayesian Capital Management, LP1,869$236.0K0.04%
Mackenzie Financial Corp1,804$228.0K0.00%
Verition Fund Management LLC1,589$201.0K0.00%
Simplex Trading, LLC150$18.0K0.00%
International Biotechnology Trust PLC1,567$12.4K0.25%
Bell Investment Advisors, Inc66$8.00K0.00%
TCI Wealth Advisors, Inc.58$7.00K0.00%
Quadrant Capital Group LLC41$5.00K0.00%
Parallel Advisors, LLC19$2.00K0.00%
Allworth Financial LP1$00.00%
Glassman Wealth Services2$00.00%

Sold out (16)

Institutions that held Karuna Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of KRTX in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Jennison Associates LLC273,540$34.7M
Point72 Asset Management, L.P.191,800$24.3M
Walleye Capital LLC30,406$3.85M
Eversept Partners, LP15,934$2.02M
Endurant Capital Management LP15,342$1.95M
Ergoteles LLC8,381$1.06M
Graham Capital Management, L.P.4,515$572.0K
SG3 Management, LLC4,250$539.0K
Jump Financial, LLC3,400$431.0K
Two Sigma Advisers, LP2,300$292.0K
OneAscent Wealth Management LLC1,945$247.0K
Prospera Financial Services Inc1,724$219.0K
Lazard Asset Management LLC688$87.0K
Point72 Hong Kong Ltd173$22.0K
EverSource Wealth Advisors, LLC50$6.00K
TCWP LLC5$0

Not filed for Q2 2022 yet (3)

Institutions that held Karuna Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KRTX in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Teachers Retirement System of the State of Kentucky40,393$5.12M
Parametric Portfolio Associates LLC3,767$478.0K
Amalgamated Financial Corp.3,634$461.0K